Proton Tx Plus Chemo Seen Beneficial in NSCLC (CME/CE)

(MedPage Today) -- Median overall survival of 26.5 months in inoperable stage III disease
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news